Suchergebnisse - "De Leeuw, Elisabeth"

PubPharm (26)

1

A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19

enthalten in: Science translational medicine | 2023

von Van Damme, K. | Hoste, L. | Declercq, J. | +20

2

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

enthalten in: Cell reports. Medicine | 2022

von Bosteels, C. | Van Damme, K. | De Leeuw, E. | +30

3

Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection : from prognostic marker to therapeutic agent

enthalten in: Cytokine | 2022

von Declercq, J. | De Leeuw, E. | Lambrecht, B.

4

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19 : an open-label randomized controlled trial

enthalten in: Respiratory research | 2022

von De Leeuw, E. | Van Damme, K. | Declercq, J. | +25

5

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial

enthalten in: Respiratory research | 2022

von De Leeuw, E. | Van Damme, K. | Declercq, J. | +25

6

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with Covid-19: an open-label randomized controlled trial

enthalten in: ResearchSquare.com | 2022

von De Leeuw, E. | Damme, K. | Declercq, J. | +25

7

TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

enthalten in: The Journal of experimental medicine | 2022

von Hoste, L. | Roels, L. | Naesens, L. | +80

8

Isolation of Conventional Murine Lung Dendritic Cell Subsets

enthalten in: Methods in molecular biology (Clifton, N.J.) | 2022

von De Leeuw, E. | Bosteels, C. | Lambrecht, B. | +1

9

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Declercq, J. | Van Damme, K. | De Leeuw, E. | +40

CommentIn: Lancet Respir Med. 2021 Dec;9(12):1353-1354. - PMID 34756179

10

Early treatment with inhaled GM-CSF improves oxygenation and anti-viral immunity in COVID-19 induced lung injury – a randomized clinical trial

enthalten in: ResearchSquare.com | 2021

von Bosteels, C. | Damme, K. | De Leeuw, E. | +28